25% healthcare staff infected despite taking 2 jabs in Delhi: Study

New Delhi: A little more than 25 per cent of healthcare workers were infected with coronavirus despite getting fully jabbed, a recent study has revealed, giving an insight on the breakthrough infections due to the Delta variant.

The study, jointly conducted by the Institute of Genomics and Integrative Biology (IGIB) and Max hospitals in Delhi-NCR, found that vaccination breakthroughs were far more common during the Delta-outbreak in Delhi than previously reported.

However, the severity of the infection was low and vaccination is crucial to avoid severe illnesses, said Shantanu Sengupta, senior scientist with the IGIB and one of the lead researchers of the study.

He also cautioned that of the 25 per cent who were infected, a large number were asymptomatic, so masking is also very important to arrest the spread of infection.

Sengupta said nearly 95 healthcare workers who had taken the two doses were studied. They were assessed from 45-90 days after their inoculation. Of the 95, more than 25 per cent saw breakthrough infections.

“Immunisation is expected to confer protection against infection and severe disease for vaccines, while reducing risks to non-immunised population by inhibiting transmission. Here, based on serial serological studies, we show that during a severe SARS-CoV2 Delta-variant outbreak in Delhi, 25.3 per cent of previously uninfected, ChAdOx1-nCoV19 (Covishield) double vaccinated, healthcare-workers (HCW) were infected within a period of less than two months, based on serology,” the study said.

Most infections were unrecognised. PTI

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs